Type 1 diabetes in pediatrics during the COVID-19 pandemic : Time from symptom onset and forms of presentation at a referral hospital
Sociedad Argentina de Pediatría..
Introduction. The COVID-19 pandemic impacted on the health care of patients with type 1 diabetes mellitus (DM1). An increase in diabetic ketoacidosis (DKA) as a form of diagnosis was reported. Objectives. To assess whether there were changes in the time from symptom onset, the causes of hospitalization due to DM1, and the proportion of severe forms, and to describe SARS-CoV-2 infection in these patients. Population and methods. Cross-sectional study in patients younger than 19 years hospitalized due to DM1 from March 2018 to August 2019 (pre-pandemic) and from March 2020 to August 2021 (pandemic). Results. The assessment included 135 hospitalizations in the pre-pandemic period and 96 during the pandemic. The time from symptom onset during the pandemic in those with debut of diabetes was shorter than in the pre-pandemic period (18.8 ± 10.2 versus 52.1 ± 12.1 days, respectively; p < 0.001). Hospitalizations due to all forms of diabetes debut and debut with DKA were more common during the pandemic than before it (59.4% versus 39.3%; odds ratio [OR]: 2.3; 95% confidence interval [CI]: 1.3-3.8; p = 0.003 and 40.6% versus 20.7%; OR: 2.6; 95% CI: 1.4-5.2; p = 0.006, respectively). Severe forms of DKA did not change between both periods (48.1% versus 59.9%; p = 0.3). Only 6 patients developed SARS-CoV-2 infection; 3 were severe. Conclusion. During the pandemic, the time from symptom onset decreased and the frequency of hospitalizations due to debut of DM1 increased. The proportion of severe forms of DKA did not change.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Archivos argentinos de pediatria - (2024) vom: 25. Apr., Seite e202310291 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Diabetes tipo 1 en pediatría durante la pandemia por COVID-19: tiempo de evolución de síntomas y formas de presentación en un centro de referencia |
|---|
| Beteiligte Personen: |
Andrés, María E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 pandemic |
|---|
| Anmerkungen: |
Date Revised 24.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.5546/aap.2023-10291.eng |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371457157 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371457157 | ||
| 003 | DE-627 | ||
| 005 | 20240426000202.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240426s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5546/aap.2023-10291.eng |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1387.xml |
| 035 | |a (DE-627)NLM371457157 | ||
| 035 | |a (NLM)38656825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Andrés, María E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Type 1 diabetes in pediatrics during the COVID-19 pandemic |b Time from symptom onset and forms of presentation at a referral hospital |
| 246 | 3 | 3 | |a Diabetes tipo 1 en pediatría durante la pandemia por COVID-19: tiempo de evolución de síntomas y formas de presentación en un centro de referencia |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Sociedad Argentina de Pediatría. | ||
| 520 | |a Introduction. The COVID-19 pandemic impacted on the health care of patients with type 1 diabetes mellitus (DM1). An increase in diabetic ketoacidosis (DKA) as a form of diagnosis was reported. Objectives. To assess whether there were changes in the time from symptom onset, the causes of hospitalization due to DM1, and the proportion of severe forms, and to describe SARS-CoV-2 infection in these patients. Population and methods. Cross-sectional study in patients younger than 19 years hospitalized due to DM1 from March 2018 to August 2019 (pre-pandemic) and from March 2020 to August 2021 (pandemic). Results. The assessment included 135 hospitalizations in the pre-pandemic period and 96 during the pandemic. The time from symptom onset during the pandemic in those with debut of diabetes was shorter than in the pre-pandemic period (18.8 ± 10.2 versus 52.1 ± 12.1 days, respectively; p < 0.001). Hospitalizations due to all forms of diabetes debut and debut with DKA were more common during the pandemic than before it (59.4% versus 39.3%; odds ratio [OR]: 2.3; 95% confidence interval [CI]: 1.3-3.8; p = 0.003 and 40.6% versus 20.7%; OR: 2.6; 95% CI: 1.4-5.2; p = 0.006, respectively). Severe forms of DKA did not change between both periods (48.1% versus 59.9%; p = 0.3). Only 6 patients developed SARS-CoV-2 infection; 3 were severe. Conclusion. During the pandemic, the time from symptom onset decreased and the frequency of hospitalizations due to debut of DM1 increased. The proportion of severe forms of DKA did not change | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 pandemic | |
| 650 | 4 | |a diabetic ketoacidosis | |
| 650 | 4 | |a type 1 diabetes mellitus | |
| 700 | 1 | |a Grimberg, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Torres, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Ferraro, Mabel |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez, Verónica |e verfasserin |4 aut | |
| 700 | 1 | |a Linari, María A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archivos argentinos de pediatria |d 1945 |g (2024) vom: 25. Apr., Seite e202310291 |w (DE-627)NLM040810917 |x 1668-3501 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:25 |g month:04 |g pages:e202310291 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5546/aap.2023-10291.eng |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 25 |c 04 |h e202310291 | ||